Connor, Clark & Lunn Investment Management Ltd.
Position in CERS — Cerus Corp
CIK 1596800
VANCOUVER, A1
Position in CERS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1,250,152
-$95,419 QoQ
Shares Held
686,897
+5.2% QoQ
Ownership
0.343%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $142,528,439 across 16 Medical Devices names. CERS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
807,369 | $50,662,404 | |
| 2 | EW |
Edwards Lifesciences Corp
|
407,842 | $32,659,987 | |
| 3 | ABT |
Abbott Laboratories
|
261,063 | $26,803,338 | |
| 4 | NVCR |
NovoCure Ltd
|
716,539 | $7,810,275 | |
| 5 | IRTC |
iRhythm Holdings, Inc.
|
42,346 | $4,997,674 | |
| 6 | AXGN |
Axogen, Inc.
|
149,328 | $4,947,236 | |
| 7 | ATEC |
Alphatec Holdings, Inc.
|
381,020 | $4,145,497 | |
| 8 | VREX |
Varex Imaging Corp
|
312,740 | $3,318,171 |
All Filings in CERS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,250,152 | 686,897 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,345,571 | 653,190 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $436,835 | 274,739 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $417,499 | 296,099 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $275,924 | 198,507 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $322,238 | 209,246 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $352,546 | 202,613 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||